Jump to content


Advertisement

Photo
- - - - -

Google- Ferring Pharmaceuticals Acquires Licensing Rights for Elobixibat from Albireo AB - MarketWatch (press release)

Started by Health Reporter , Jul 03 2012 03:02 AM

  • Please log in to reply
No replies to this topic

#1 Health Reporter

Health Reporter

    Newsfeeder

  • RSS
  • PipPipPipPip
  • 44,027 posts
  • Country:United States

Posted 03 July 2012 - 03:02 AM

Advertisement
Ferring Pharmaceuticals Acquires Licensing Rights for Elobixibat from Albireo ABMarketWatch (press release)The prevalence of severe CIC and IBS-C is high and patients are not satisfied with current available treatments. Elobixibat has the potential to become a safe and effective treatment alternative for this group of patients and increase patient quality ...and more »
View the full article

Advertisement
Back to IBS Reporter NewsFeed



Advertisement


About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service

Irritable Bowel Syndrome |  Inflammatory Bowel Disease |  Crohn's Disease |  Ulcerative Colitis |  Fibromyalgia |  GERD - Reflux Disease


©Copyright 1995-2013 All rights reserved IBS Self Help and Support Group

Website Monitoring by: AlertBot



This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here

  1. IBS Self Help and Support Group Forums - IBSgroup.org
  2. → Irritable Bowel Syndrome
  3. → IBS Reporter NewsFeed
  4. Privacy Statement